CVE-2015-3958

CVE-2015-3958 is a high-severity vulnerability in Hospira Lifecare Pcainfusion Firmware with a CVSS 2.0 base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-19.

Key facts

Description

Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets.

Frequently asked questions

What is CVE-2015-3958?
Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets.
How severe is CVE-2015-3958?
CVE-2015-3958 has a CVSS 2.0 base score of 7.8, rated high severity.
Is CVE-2015-3958 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (84th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2015-3958?
CVE-2015-3958 affects Hospira Lifecare Pcainfusion Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2015-3958?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2015-3958 published?
CVE-2015-3958 was published on 2015-07-06 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Hospira Lifecare Pcainfusion Firmware

All CVEs affecting Hospira Lifecare Pcainfusion Firmware →

Other CWE-19 vulnerabilities

Browse all CWE-19 vulnerabilities →